Breaking News Instant updates and real-time market news.

HCA

HCA Holdings

$86.64

0.07 (0.08%)

, LPNT

LifePoint

$65.40

0.3 (0.46%)

17:25
07/16/17
07/16
17:25
07/16/17
17:25

Senate to delay health care legislation vote, Reuters reports

The U.S. Senate will delay its consideration of health care legislation while Arizona Republican Senator John McCain recuperates from surgery, according to Reuters, citing Senate Republican leader Mitch McConnell. McCain's absence cast doubt on whether the Senate would be able to pass the legislation to dismantle and replace Obamacare, the report noted. Publicly traded hospital operators include HCA Holdings (HCA), LifePoint (LPNT), Tenet Healthcare (THC), Community Health (CYH) and Quorum Health (QHC), and health insurance providers include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).Reference Link

HCA

HCA Holdings

$86.64

0.07 (0.08%)

LPNT

LifePoint

$65.40

0.3 (0.46%)

THC

Tenet

$19.09

0.1 (0.53%)

CYH

Community Health

$9.26

-0.04 (-0.43%)

QHC

Quorum Health

AET

Aetna

$155.27

0.23 (0.15%)

ANTM

Anthem

$192.56

0.01 (0.01%)

CNC

Centene

$82.80

0.4 (0.49%)

CI

Cigna

$173.80

0.75 (0.43%)

HUM

Humana

$239.09

1.03 (0.43%)

MOH

Molina Healthcare

$70.20

-0.95 (-1.34%)

UNH

UnitedHealth

$186.90

1.42 (0.77%)

WCG

WellCare

$182.21

-0.26 (-0.14%)

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 02

    Aug

  • 03

    Aug

  • 04

    Aug

  • 04

    Aug

  • 08

    Aug

  • 14

    Aug

  • 23

    Aug

  • 26

    Sep

  • 27

    Sep

HCA HCA Holdings
$86.64

0.07 (0.08%)

06/28/17
ARGS
06/28/17
INITIATION
ARGS
Buy
HCA Holdings initiated with a Buy at Argus
Argus analyst Stephen Biggar started coverage of HCA with a $100 price target and a Buy rating. He expects HCA to benefit from small increases in demand and average revenue per admission this year. The analyst expects the company's revenue growth to accelerate next year due to "slightly better demand trends and a small improvement in payor mix." He predicts that the company's margins will rise slightly in 2018, driven by cost controls and more favorable customer mix.
06/23/17
LEER
06/23/17
NO CHANGE
LEER
Outperform
Draft version of Senate healthcare bill better than expected, says Leerink
Leerink analyst Ana Gupte said she views the draft version of the Senate healthcare bill as better than expected, stating that stabilization of the Exchanges and risk stabilization is a direct positive for health insurers and indirect positive for facility operators. The Senate bill maintains the House bill's plan to repeal all "ObamaCare" industry fees and taxes, which is a positive for Managed Care and Medical Technology players, Gupte adds. She keeps Outperform ratings on Anthem (ANTM), UnitedHealth (UNH), Cigna (CI), Humana (HUM), WellCare (WCG), Molina Healthcare (MOH) and acute care hospital operators HCA Holdings (HCA), Tenet (THC) and LifePoint (LPNT).
06/07/17
LEER
06/07/17
UPGRADE
LEER
Outperform
Leerink upgrades hospitals HCA, LifePoint, Tenet to Outperform
Leerink analyst Ana Gupte last night upgraded hospitals HCA Holdings (HCA), LifePoint (LPNT) and Tenet healthcare (THC) to Outperform from Market Perform. She raised her price target for HCA to $100 from $90, for LifePoint to $74 from $73 and maintains a $27 price target for HCA. The targets offer upside of 21%, 20% and 62% respectively. Anthem's (ANTM) announced exit yesterday from the key swing state of Ohio's healthcare exchange could bring further attention to the need for stabilization funding through legislation, Gupte tells investors in a research note. She believes improving policy under the Trump Administration could drive upside to 2018 and 2019 consensus estimates. Further, the analyst thinks medium term downside risk from Republican's repeal and replace healthcare bill is likely better than feared as publicly traded hospitals are "heavily weighted to non-expansion states," which lessons the impact of Medicaid expansion funding cuts.
06/06/17
LEER
06/06/17
UPGRADE
LEER
Outperform
HCA Holdings upgraded to Outperform from Market Perform at Leerink
LPNT LifePoint
$65.40

0.3 (0.46%)

06/06/17
MSCO
06/06/17
INITIATION
Target $65
MSCO
Equal Weight
LifePoint initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated LifePoint with an Equal Weight rating and $65 price target, citing volume and price pressures on the hospital industry expected over the next several years.
06/06/17
LEER
06/06/17
UPGRADE
LEER
Outperform
LifePoint upgraded to Outperform from Market Perform at Leerink
THC Tenet
$19.09

0.1 (0.53%)

06/07/17
06/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ormat Technologies (ORA) upgraded to Overweight from Neutral at JPMorgan with analyst Paul Coster saying he believes the company is well positioned to continue posting revenue growth and margin expansion over the next few years. 2. Tenet (THC) upgraded to Outperform from Market Perform at Leerink. 3. Cott Corp. (COT) and Dr Pepper Snapple (DPS) were upgraded to Outperform from Market Perform at BMO Capital. 4. Sun Life Financial (SLF) upgraded to Outperform from Sector Perform at RBC Capital with analyst Darko Mihelic saying net flows and Assets Under Management at the company's MFS unit have improved over the last two months. He also notes that the stock has fallen about 12% since February. 5. Valvoline (VVV) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying he expects the oil market to return to looser supply/demand and pricing to decline in the summer once Motiva completes its Port Arthur, TX turnaround in June, which would be a positive for Valvoline margins. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/06/17
LEER
06/06/17
UPGRADE
LEER
Outperform
Tenet upgraded to Outperform from Market Perform at Leerink
CYH Community Health
$9.26

-0.04 (-0.43%)

03/13/17
MZHO
03/13/17
NO CHANGE
Target $7.5
MZHO
Neutral
Community Health unlikely to be taken private by Shanda, says Mizuho
Mizuho analyst Sheryl Skolnick noted that Tianqiao Chen and the Shanda group of entities, which are the largest shareholder of Community Health Systems, changed their filing status to active from passive. However, Community Health's high leverage make a go-private deal unlikely and put a limit on her "enthusiasm and the upward move of the stock" on the news of an activist shareholder, Skolnick tells investors. She keeps a Neutral rating on Community Health shares.
05/31/17
PIPR
05/31/17
NO CHANGE
PIPR
Piper raises 'early caution flag' for Q2 hospital earnings
Following her firm's May outpatient survey, Piper Jaffray analyst Sarah James is putting up an "early caution flag" for Q2 hospital earnings. The May outpatient survey indicates April was the peak, declining in May, with indications that June could be below April as well, James tells investors in a research note. After four months of increases, the outpatient survey declined 50 basis points from the April peak to 2.5% year-over-year same-hospital admissions in May, the analyst adds. She views the decline as concerning amid "tenuous" investor sentiment and "optimistic" Q2 expectations. Hospitals that Piper covers include Community Health (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS).
04/05/17
DBAB
04/05/17
INITIATION
Target $11
DBAB
Hold
Community Health initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Chris Rigg started Community Health Systems with a Hold rating and $11 price target.
06/06/17
MSCO
06/06/17
INITIATION
Target $10
MSCO
Underweight
Community Health initiated with an Underweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Community Health with an Underweight and a $10 price target citing valuation and said he sees downside if there are not more signs of a turnaround.
QHC Quorum Health

04/04/17
DBAB
04/04/17
INITIATION
DBAB
Hold
Quorum Health initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Chris Rigg initiated Quorom Health with a Hold rating and a $5 price target.
05/12/17
05/12/17
NO CHANGE

Quorum Health signs agreement to divest two hospitals in Tennessee
Quorum Health has signed a definitive agreement to sell 45-bed Henderson County Community Hospital in Lexington, Tennessee, and 45-bed McKenzie Regional Hospital in McKenzie, Tennessee, and their associated assets, to SSH Tennessee. The divestiture is expected to close by August 1, subject to customary regulatory approvals and closing conditions.
06/06/17
MSCO
06/06/17
INITIATION
Target $3
MSCO
Underweight
Quorum Health initiated with an Underweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Quorum Health with an Underweight and a $3 price target saying long-term growth remains a questions and unemployment is higher than average in the company's markets.
08/11/16
08/11/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wendy's (WEN) downgraded to Buy from Conviction Buy at Goldman with analyst Karen Holthouse citing execution risk and the potential for additional fiscal 2016 same-store sales guidance reductions. 2. Bristol-Myers (BMY) downgraded to Hold from Buy at Berenberg. 3. Public Storage (PSA) downgraded to Neutral from Buy at BofA/Merrill with analyst Jeffery Spector citing valuation and increasing concessions in weaker markets. 4. Lam Research (LRCX) downgraded to Neutral from Buy at Nomura with analyst Romit Shah citing the extended timeline for its merger with KLA-Tencor (KLAC) after the Department of Justice requested more information. 5. Quorum Health (QHC) downgraded to Sell from Neutral at UBS with analyst A.J. Rice saying the company's earnings power is "much less than thought" after its second quarter results missed expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AET Aetna
$155.27

0.23 (0.15%)

06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
06/28/17
SBSH
06/28/17
INITIATION
Target $180
SBSH
Buy
Aetna initiated with a Buy, added to Focus List at Citi
Citi analyst Ralph Giacobbe started Aetna with a Buy rating and $180 price target and added the shares to his firm's Focus List. The analyst calls Aetna his new top pick in Managed Care. The company is a "strong diversified" health insurer that is well positioned to capture lives within its government segment, Giacobbe contends.
06/28/17
SBSH
06/28/17
NO CHANGE
Target $205
SBSH
Buy
Anthem removed from Focus List at Citi
Citi analyst Ralph Giacobbe removed Anthem (ANTM) from his firm's Focus List but keeps a Buy rating on the shares with a $205 price target. The analyst believes some of the upside catalysts have played out. He also added Aetna (AET) to the Focus List.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ANTM Anthem
$192.56

0.01 (0.01%)

06/08/17
COWN
06/08/17
NO CHANGE
Target $83
COWN
Outperform
Express Scripts concerns of margin compression unwarranted, says Cowen
Cowen analyst Charles Ryhee said concern of margin compression at Express Scripts is unfounded as the company not only receives profits from claims but also prescription drug plan premiums, its rebate administration business, and other business operations. He believes the Express Scripts business mix is the reason for a higher EBITDA per adjusted claim. Ryhee maintained his Outperform rating and $83 price target on Express Scripts shares.
CNC Centene
$82.80

0.4 (0.49%)

05/22/17
05/22/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Momenta (MNTA) downgraded to Equal Weight from Overweight at Barclays with analyst Douglas Tsao citing the likelihood of generic manufacturers, most notably Mylan (MYL), winning approval for generic Copaxone in the coming months. He lowered his price target for the shares to $17 from $20. 2. Zoe's Kitchen (ZOES) downgraded to Neutral from Outperform at Baird with analyst David Tarantino saying he believes the near-term risk profile looks elevated amid signs of sluggish comps for similarly positioned chains and an uptrend in input costs. Tarantino lowered his price target to $20 from $25 on Zoe's Kitchen shares. 3. Arista Networks (ANET) downgraded to Neutral from Buy at DA Davidson with analyst Mark Kelleher citing valuation with the shares up 60% since his initiation in January. 4. Synchronoss (SNCR) downgraded to Underperform from Neutral at Credit Suisse with analyst Michael Nemeroff citing AT&T's (T) recent announcement that it will be closing the personal cloud "Locker" storage service offering powered by Synchronoss on August 3. 5. Centene (CNC) downgraded to Neutral from Overweight at JPMorgan with analyst Gary Taylor citing valuation with the shares up 32% since December 2016. The stock reflects very little probability of Senate Medicaid cuts or block grants, Taylor tells investors in a research note. He keeps a $75 price target for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/17
JPMS
05/22/17
DOWNGRADE
Target $75
JPMS
Neutral
Centene downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Gary Taylor downgraded Centene to Neutral citing valuation with the shares up 32% since December 2016. The stock reflects very little probability of Senate Medicaid cuts or block grants, Taylor tells investors in a research note. He keeps a $75 price target for the shares.
06/06/17
MSCO
06/06/17
INITIATION
Target $86
MSCO
Overweight
Centene initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Centene with an Overweight and a $86 price target. The analyst thinks the HealthNet acquisition provides diversification and entry planned expansion in Medicare Advantage could offset potential headwinds.
CI Cigna
$173.80

0.75 (0.43%)

06/15/17
OPCO
06/15/17
NO CHANGE
Target $185
OPCO
Outperform
Cigna price target raised to $185 from $174 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Cigna to $185 saying the company well positioned heading into the upcoming investor day. Cigna should be able to deploy $5.6B in capital that could be worth $1.65 in earnings per share through share repurchases, Wiederhorn tells investors in a research note. He would continue to be a buyer of the shares at current share levels.
06/16/17
06/16/17
NO CHANGE

Leerink reiterates view that Cigna could bid for Humana
Leerink analyst Ana Gupte reiterated his views that Cigna (CI) could make a bid Humana (HUM) following Cigna's disclosure that 60% of its Medicare Advantage plans will be in 4-STAR rated plans. The announcement is most positive for Humana (HUM) which is the largest pure play Medicare Advantage name, but also paves the way for Cigna to potentially dievest its legacy HS Medicare Advantage book and bid for Humana.
HUM Humana
$239.09

1.03 (0.43%)

06/28/17
SBSH
06/28/17
INITIATION
Target $275
SBSH
Buy
Humana initiated with a Buy at Citi
Citi analyst Ralph Giacobbe started Humana with a Buy rating and $275 price target. The company has built a "strong and coveted" Medicare Advantage franchise that should deliver "strong" growth, the analyst contends. He also believes a potential takeout will provide valuation support.
MOH Molina Healthcare
$70.20

-0.95 (-1.34%)

06/14/17
LEER
06/14/17
NO CHANGE
Target $80
LEER
Outperform
Molina Healthcare price target raised to $80 from $70 at Leerink
Leerink analyst Ana Gupte raised her price target for Molina Healthcare shares to $80 and remains "bullish" on the name after a call with CFO and interim CEO Joseph White. The analyst says White aligned with her view that the upcoming re-procurement of State Medicaid contracts "does not pose meaningful downside risk." Further, she learned the CEO search is making good progress with an "attractive slate" of senior executives with Managed Care experience. The analyst keeps an Outperform rating on Molina.
06/06/17
MSCO
06/06/17
INITIATION
Target $65
MSCO
Underweight
Molina Healthcare initiated with an Underweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Molina Healthcare with an Underweight and a $65 price target citing premium valuation, uncertainties over management's strategy, and the impact of healthcare reform to Medicaid.
UNH UnitedHealth
$186.90

1.42 (0.77%)

06/08/17
JPMS
06/08/17
NO CHANGE
JPMS
Overweight
Humana takeover still likely, $300 bid possible, says JPMorgan
After hosting investor meetings with management, JPMorgan analyst Gary Taylor says a possible sale of Humana (HUM) is still likely. The company's Medicare Advantage assets are coveted by every other publicly traded health plan and likely pharmacy benefit managers/drug stores, Taylor tells investors in a research note. He thinks Humana management is well prepared to discuss the possibilities of both health plan and PBM or drug store integration. The analyst continues to believe Cigna (CI) is the most plausible candidate, presuming a simultaneous sale of HealthSpring, to buy Humana. He sees the potential for a $250-$300 per share bid. Humana closed yesterday up 25c to $233.75. Along with Cigna, publicly traded health plans include Aetna (AET), Anthem (ANTM) and UnitedHealth (UNH). Express Scripts (EXRX) and CVS Health (CVS) are pharmacy benefit managers.
06/27/17
KEYB
06/27/17
DOWNGRADE
KEYB
Sector Weight
LabCorp downgraded on potential acquisition at KeyBanc
As noted earlier, KeyBanc downgraded LabCorp to Sector Weight from Overweight. Analyst Donald Hooker downgraded the stock based on his belief that the company implied that it may make an "expensive" deal to acquire a contract research organization. The analyst adds that the upcoming renewal of the company's contract with UnitedHealth (UNH) in 2H18 creates uncertainty.He expects to hear news about the deal "in coming months."
WCG WellCare
$182.21

-0.26 (-0.14%)

05/05/17
WOLF
05/05/17
INITIATION
Target $179
WOLF
Peer Perform
WellCare initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated WellCare with a Peer Perform and a $179 price target given a more tepid intermediate view on Medicaid outlook and high investor expectations.
06/06/17
MSCO
06/06/17
INITIATION
Target $183
MSCO
Equal Weight
WellCare initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated WellCare with an Equal Weight rating and $183 price target, citing its current valuation.

TODAY'S FREE FLY STORIES

COH

Coach

$48.08

-0.07 (-0.15%)

08:52
07/21/17
07/21
08:52
07/21/17
08:52
Upgrade
Coach rating change  »

Coach upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INDB

Independent Bank

$66.35

-0.35 (-0.52%)

08:52
07/21/17
07/21
08:52
07/21/17
08:52
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

AKBA

Akebia

, MACK

Merrimack

$1.30

0.02 (1.56%)

08:51
07/21/17
07/21
08:51
07/21/17
08:51
Periodicals
Former Akebia employee faces losing bail in insider trading case, Reuters says »

Schultz Chan, former…

AKBA

Akebia

MACK

Merrimack

$1.30

0.02 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$20.60

0.75 (3.78%)

08:51
07/21/17
07/21
08:51
07/21/17
08:51
Initiation
AMC Entertainment initiated  »

AMC Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 05

    Sep

SIX

Six Flags

$56.28

-1.01 (-1.76%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Initiation
Six Flags initiated  »

Six Flags initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

LYV

Live Nation

$36.38

-0.01 (-0.03%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Initiation
Live Nation initiated  »

Live Nation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$106.14

-1.7 (-1.58%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Recommendations
Union Pacific analyst commentary  »

Market ignorning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

MTN

Vail Resorts

$206.11

0.09 (0.04%)

08:50
07/21/17
07/21
08:50
07/21/17
08:50
Initiation
Vail Resorts initiated  »

Vail Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$26.69

-0.25 (-0.93%)

08:49
07/21/17
07/21
08:49
07/21/17
08:49
Hot Stocks
Breaking Hot Stocks news story on General Electric »

General Electric down 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 02

    Oct

GPC

Genuine Parts

$81.69

-1.27 (-1.53%)

08:47
07/21/17
07/21
08:47
07/21/17
08:47
Upgrade
Genuine Parts rating change  »

Genuine Parts upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$67.02

-0.42 (-0.62%)

08:46
07/21/17
07/21
08:46
07/21/17
08:46
Hot Stocks
Schlumberger says expects to double SPM revenue over next two years »

Says has invested $4.3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

GE

General Electric

$26.69

-0.25 (-0.93%)

08:45
07/21/17
07/21
08:45
07/21/17
08:45
Hot Stocks
General Electric CFO says 'trending to bottom end' of $1.60-$1.70 FY17 EPS view »

GE CFO Jeff Bornstein…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 02

    Oct

ITW

Illinois Tool Works

$147.12

-0.56 (-0.38%)

08:45
07/21/17
07/21
08:45
07/21/17
08:45
Technical Analysis
Technical Earnings Preview: Illinois Tool Works in uptrend ahead of news »

The shares have been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

XRT

S&P Retail Index SPDR

$40.59

0.09 (0.22%)

, PAA

Plains All American

$26.47

-0.16 (-0.60%)

08:45
07/21/17
07/21
08:45
07/21/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

XRT

S&P Retail Index SPDR

$40.59

0.09 (0.22%)

PAA

Plains All American

$26.47

-0.16 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Nov

SLB

Schlumberger

$67.02

-0.42 (-0.62%)

08:41
07/21/17
07/21
08:41
07/21/17
08:41
Hot Stocks
Schlumberger says all U.S. product lines profitable in Q2 »

Says expect high demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

HIMX

Himax

$8.86

0.34 (3.99%)

08:41
07/21/17
07/21
08:41
07/21/17
08:41
Downgrade
Himax rating change  »

Himax downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 05

    Sep

SLM

Sallie Mae

$10.98

-0.83 (-7.03%)

08:41
07/21/17
07/21
08:41
07/21/17
08:41
Recommendations
Sallie Mae analyst commentary  »

Sallie Mae shares should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$67.02

-0.42 (-0.62%)

08:38
07/21/17
07/21
08:38
07/21/17
08:38
Hot Stocks
Schlumberger says 'confident' in delivering free cash flow target for 2017 »

Comments from Q2 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

EXPI

eXp World Holdings

$2.95

-0.04 (-1.34%)

08:36
07/21/17
07/21
08:36
07/21/17
08:36
Initiation
eXp World Holdings initiated  »

eXp World Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CXDC

China XD Plastics

$4.70

-0.025 (-0.53%)

08:35
07/21/17
07/21
08:35
07/21/17
08:35
Hot Stocks
China XD Plastics signs investment agreements for $614M in Harbin, China »

China XD Plastics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAAP

Advanced Accelerator

$41.13

0.56 (1.38%)

08:35
07/21/17
07/21
08:35
07/21/17
08:35
Hot Stocks
Advanced Accelerator: CHMP opinion recommending approval of 177Lu oxodotreotide »

Advanced Accelerator…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$13.59

-0.56 (-3.96%)

, YDKN

Acquired by FNB

08:35
07/21/17
07/21
08:35
07/21/17
08:35
Recommendations
F.N.B., Acquired by FNB analyst commentary  »

F.N.B. weakness overdone,…

FNB

F.N.B.

$13.59

-0.56 (-3.96%)

YDKN

Acquired by FNB

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OFG

OFG Bancorp

$9.85

-0.1 (-1.01%)

08:34
07/21/17
07/21
08:34
07/21/17
08:34
Earnings
OFG Bancorp reports Q2 EPS 30c, consensus 27c »

OFG Bancorp reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

ENDP

Endo

$12.32

0.24 (1.99%)

08:32
07/21/17
07/21
08:32
07/21/17
08:32
Hot Stocks
Endo closing Huntsville manufacturing and distribution facilities »

Endo will be ceasing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

ADS

Alliance Data

$238.62

-24.91 (-9.45%)

08:30
07/21/17
07/21
08:30
07/21/17
08:30
Recommendations
Alliance Data analyst commentary  »

Alliance Data weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.